Aptevo Therapeutics and the ADAPTIR™ (Modular Protein Technology) Platform: The Future of Immuno-oncology
Aptevo Therapeutics is a biotechnology company focused on developing novel oncology and hematology therapeutics to meaningfully improve patients’ lives. Our core technology is the ADAPTIR™ (modular protein technology) platform. We also have four commercial products that generate revenue in the areas of hematology and infectious diseases, as well as various investigational stage product candidates in immuno-oncology.
Apr 16, 2018
8:00 AM CDTAmerican Association for Cancer Research 2018 Annual Meeting
Mar 13, 2018
12:00 PM PDT30th Annual ROTH Conference
Mar 10, 2018Thrombosis and Hemostasis 2018 Summit of North America